We are live on !
Find out more
BLB&B Advisors Portfolio holdings
AUM
$2.78B
Turnover
8.81%
1-Year Est. Return
18.83%
BLB&B Advisors, known as BLBB, is an independent, employee-owned wealth advisory firm founded in 1964 by Frank Burke and Nick Lawton. It provides financial planning and investment management to individuals and families, nonprofits and business owners. Unlike many advisers, it does not outsource investment management. Each client gets a team with a wealth advisor, a financial planner and a client service administrator.
This Fund
S&P 500
This Quarter Est. Return
+5.46%
1 Year Est. Return
+18.83%
3 Year Est. Return
+82.03%
5 Year Est. Return
+80.22%
10 Year Est. Return
+238.94%
AUM
$468M
AUM Growth
+$14.1M
(+3.1%)
Cap. Flow
-$5.76M
Cap. Flow % of AUM
Cap. Flow %
-1.23%
Top 10 Holdings %
Top 10 Hldgs %
24.61%
Holding
300
New
25
Increased
74
Reduced
129
Closed
17
Avg Time Held
0.8
years
Top 10 Avg Time Held
0.8
years
Top 20 Avg Time Held
0.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Civeo
CVEO
|
+$781K |
| 2 |
Kulicke & Soffa
KLIC
|
+$708K |
| 3 |
Sysco
SYY
|
+$658K |
| 4 |
GS Connect S&P GSCI Enhanced Commodity Total Return Strategy Index ETN (maturity subject to postpone
GSC
|
+$621K |
| 5 |
KING
KING DIGITAL ENTMT PLC ORD SHS (IRL)
KING
|
+$602K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$1.39M |
| 2 |
L3Harris
LHX
|
+$1.31M |
| 3 |
Vanguard Morningstar Growth ETF
VUG
|
+$1.28M |
| 4 |
RPXC
RPX Corporation
RPXC
|
+$1.26M |
| 5 |
Vanguard Morningstar Small-Cap Growth ETF
VBK
|
+$889K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.09% |
| 2 | Industrials | 14.9% |
| 3 | Miscellaneous | 14.51% |
| 4 | Healthcare | 12.44% |
| 5 | Energy | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
ExxonMobil
XOM
$677B
| $15.9M | 3.4% |
158,196
-1,572
| -1% | -$159K |
2013 Q2
4 quarters
|
|
2
IBM
IBM
$235B
| $14.4M | 3.08% |
83,162
-1,361
| -2% | -$245K |
2013 Q2
4 quarters
|
|
3
Intel
INTC
$334B
| $12.8M | 2.73% |
413,411
+11,468
| +3% | +$314K |
2013 Q2
4 quarters
|
|
4
GE Aerospace
GE
$354B
| $12.1M | 2.59% |
96,367
+517
| +0.5% | +$65.8K |
2013 Q2
4 quarters
|
|
|
AXAS
5
DELISTED
Abraxas Petroleum Corp
AXAS
| $11.4M | 2.43% |
90,788
-535
| -0.6% | -$54.6K |
2013 Q2
4 quarters
|
|
6
Johnson & Johnson
JNJ
$674B
| $11.3M | 2.41% |
107,797
+2,021
| +2% | +$204K |
2013 Q2
4 quarters
|
|
7
Verizon
VZ
$192B
| $10.5M | 2.24% |
214,510
+10,054
| +5% | +$487K |
2013 Q2
4 quarters
|
|
8
AT&T
T
$149B
| $9M | 1.92% |
336,921
-5,447
| -2% | -$146K |
2013 Q2
4 quarters
|
|
9
Chevron
CVX
$414B
| $8.92M | 1.91% |
68,368
-110
| -0.2% | -$13.7K |
2013 Q2
4 quarters
|
|
10
Corning
GLW
$104B
| $8.88M | 1.9% |
404,547
-5,010
| -1% | -$106K |
2013 Q2
4 quarters
|
|
11
Procter & Gamble
PG
$388B
| $7.69M | 1.64% |
97,891
+6,084
| +7% | +$491K |
2013 Q2
4 quarters
|
|
12
Microsoft
MSFT
$3.86T
| $7.58M | 1.62% |
181,751
+5,658
| +3% | +$229K |
2013 Q2
4 quarters
|
|
13
3M
MMM
$97.8B
| $7.36M | 1.57% |
61,423
-1,097
| -2% | -$129K |
2013 Q2
4 quarters
|
|
14
Pfizer
PFE
$167B
| $7.04M | 1.51% |
250,176
+2,313
| +0.9% | +$65.9K |
2013 Q2
4 quarters
|
|
15
PPL Corp
PPL
$26.6B
| $6.48M | 1.38% |
195,724
+4,024
| +2% | +$127K |
2013 Q2
4 quarters
|
|
16
Merck
MRK
$361B
| $6.39M | 1.37% |
115,756
-695
| -0.6% | -$37.9K |
2013 Q2
4 quarters
|
|
17
Western Digital
WDC
$118B
| $6.17M | 1.32% |
88,488
-6,846
| -7% | -$459K |
2013 Q2
4 quarters
|
|
18
Johnson Controls International
JCI
$87.7B
| $5.62M | 1.2% |
107,442
-1,815
| -2% | -$90.3K |
2013 Q2
4 quarters
|
|
19
Vanguard FTSE Emerging Markets ETF
VWO
$121B
| $5.47M | 1.17% |
126,859
+3,357
| +3% | +$141K |
2013 Q2
4 quarters
|
|
20
JPMorgan Chase
JPM
$914B
| $5.32M | 1.14% |
92,289
-295
| -0.3% | -$16.6K |
2013 Q2
4 quarters
|
|
21
DELISTED
Du Pont De Nemours E I
DD
| $5.19M | 1.11% |
83,544
+5,856
| +8% | +$376K |
2013 Q2
4 quarters
|
|
22
Bristol-Myers Squibb
BMY
$128B
| $4.95M | 1.06% |
102,116
-950
| -0.9% | -$46.8K |
2013 Q2
4 quarters
|
|
23
CSX Corp
CSX
$95.3B
| $4.84M | 1.04% |
471,648
-4,416
| -0.9% | -$43K |
2013 Q2
4 quarters
|
|
24
Cisco
CSCO
$401B
| $4.65M | 0.99% |
187,267
+7,685
| +4% | +$183K |
2013 Q2
4 quarters
|
|
25
Vanguard Morningstar Large-Cap ETF
VV
$54.1B
| $4.63M | 0.99% |
51,417
-7,986
| -13% | -$698K |
2013 Q2
4 quarters
|
|
Similar funds
BLB&B Advisors's Q2 2014 Portfolio in Review
As of Q2 2014, BLB&B Advisors held 300 positions worth $468M, up 3.1% from $454M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
BLB&B Advisors's Q2 2014 filing shows 25 new, 74 increased, 129 reduced and 17 closed positions. Its largest new stake was Civeo: 2,610 shares worth $784K. The largest sale was Vanguard FTSE All-World ex-US ETF, an estimated $1.39M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Miscellaneous.
- BLB&B Advisors's largest Q2 2014 buy was Civeo: 2,610 shares worth $784K.
- BLB&B Advisors added most to Sysco in Q2 2014, an estimated $658K increase.
- BLB&B Advisors's biggest Q2 2014 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $1.39M.
- BLB&B Advisors fully exited L3Harris in Q2 2014, selling an estimated $1.31M.
- BLB&B Advisors's ten largest holdings make up 25% of its $468M portfolio in Q2 2014.
- BLB&B Advisors opened 25 new positions and closed 17 in Q2 2014.
- BLB&B Advisors's portfolio value rose 3.1% quarter-over-quarter to $468M.
Based on BLB&B Advisors's 13F filing for Q2 2014, filed 17 Jul 2014.